Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities
Net loss	$ (8,757,704)	$ (4,079,362)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	673,117	723,800
Milestone expense	5,000,000
Change in operating assets and liabilities:
Prepaid expenses and other assets	455,131	285,496
Accounts payable and other current liabilities	(478,519)	(485,247)
Net cash used in operating activities	(3,107,975)	(3,555,313)
Financing activities
Proceeds from issuance of common stock, net	3,330,366	5,676,388
Proceeds from paycheck protection program	104,168
Proceeds from Eversana line of credit	2,000,000
Net cash provided by financing activities	5,434,534	5,676,388
Net increase in cash and cash equivalents	2,326,559	2,121,075
Cash and cash equivalents at beginning of period	5,663,833	5,319,004
Cash and cash equivalents at end of period	$ 7,990,392	$ 7,440,079